Owner Scorecard


← All companies ← CNM Manual CNNE → ← CLPT Medical Devices & Equipment COO →

CNMD, CONMED

CONMED is a medical technology company that provides devices and equipment for surgical procedures.

The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology.

The Company's 3,900 employees distribute its products worldwide from three primary manufacturing locations.

Latest annual: FY2025 10-K
CNMD · CONMED
I

The business

What it sells, where the money comes from, the kind of company it is.

Revenue · FY2025
$1.4B
+5.2% YoY · 10% 5-yr CAGR
Vital signs · TTM, with 5-yr average
Revenue $1.4B 5-yr avg $1.2B
Gross margin 55% 5-yr avg 55%
Operating margin 7.5% 5-yr avg 10.0%
ROIC 4% 5-yr avg 6%
Owner-earnings margin 11% 5-yr avg 9%
Free cash flow margin 11% 5-yr avg 8%

The business in brief

read the 10-K →

What this business is and what moves its needle, from its own SEC filings.

What it is
Revenue is General Surgery (58%) and Orthopedic Surgery (42%).
What moves the needle
Gross margin has run about 55% and operating margin about 7.5% through the cycle, a wide spread between price and the cost of what it sells — whether that advantage is durable pricing power or a margin that can erode is the question the record is for. The operating margin has swung widely — from 4.9% to 15% — on a steadier 55% gross margin, so what moves it sits below the gross line, in operating spend and one-off charges more than in the cost of the product itself. Inventory runs near 23% of sales, so how fast it turns back into cash — and the risk of writing it down when demand softens — sits alongside the margin. Read this kind of business on the installed base and what follows it. On its own account, the filing leans hardest on customer concentration, set against the numbers in what the filing emphasizes, below.
Is it a good business?
Return on capital has rarely cleared the cost of capital (median 5%, above 15% in 0 of 9 years). By owner earnings: roughly 7% of revenue reaches owners as cash, consistently. This is price-taker territory, where the balance sheet and the cycle matter more than any multiple; the rest is in the 10-K.

Every line is arithmetic on the company's filings, shown in full in the sections below.

Where the money comes from

read the 10-K →

Revenue spreads across 2 lines, the largest General Surgery at 58%.

Revenue by product line, FY2025
  • General Surgery58%$800M
  • Orthopedic Surgery42%$575M
By geographyUnited States56%EMEA19%Asia Pacific15%Americas (excluding the United States)9%

From the segment footnote of the company's own 10-K. Shares are of total revenue; the profit bar shows each segment's share of segment operating profit, before unallocated corporate costs.

II

The record

Ten years of arithmetic, read across the cycle.

The record, 2016–2025

realized figures from each filing · older years to the left
2016’162017’172018’182019’192020’202021’212022’222023’232024’242025’25TTMTTMDec 2025
Income statement
$764M$796M$860M$955M$862M$1.0B$1.0B$1.2B$1.3B$1.4B$1.4BRevenueRevenue
53%54%55%55%53%56%55%54%56%55%55%Gross marginGross mgn
44%44%41%42%43%41%43%40%37%43%43%SG&A / revenueSG&A/rev
4%4%5%5%5%4%5%4%4%4%4%R&D / revenueR&D/rev
$38M$47M$71M$79M$46M$110M$70M$121M$200M$103M$103MOperating incomeOp. inc.
4.9%5.9%8.3%8.3%5.3%10.9%6.7%9.7%15.3%7.5%7.5%Operating marginOp. mgn
$15M$55M$41M$29M$10M$63M($81M)$64M$132M$47M$47MNet incomeNet inc.
24%19%8%14%20%19%34%34%Effective tax rateTax rate
Cash flow & returns
$40M$66M$75M$95M$65M$112M$33M$125M$167M$171M$171MOperating cash flowOp. cash
$20M$20M$19M$19M$18M$16M$16M$16M$17M$17M$17MDepreciationDeprec.
($4M)($18M)$5M$36M$24M$16M$76M$20M($8M)$78M$78MWorking capital & otherWC & other
$15M$13M$17M$20M$13M$15M$22M$19M$13M$20M$20MCapexCapex
1.9%1.6%1.9%2.1%1.5%1.5%2.1%1.5%1.0%1.4%1.4%Capex / revenueCapex/rev
$25M$53M$58M$75M$52M$97M$17M$106M$154M$151M$151MOwner earningsOwner earn.
3.3%6.6%6.8%7.9%6.0%9.6%1.7%8.5%11.8%11.0%11.0%Owner earnings marginOE mgn
$25M$53M$58M$75M$52M$97M$12M$106M$154M$151M$151MFree cash flowFCF
3.3%6.6%6.8%7.9%6.0%9.6%1.1%8.5%11.8%11.0%11.0%Free cash flow marginFCF mgn
$0$228M$0$0$0AcquisitionsAcquis.
$22M$22M$22M$23M$23M$23M$24M$25M$25M$25M$25MDividends paidDiv. paid
3%4%5%5%3%6%5%9%4%4%ROICROIC
3%9%6%4%1%8%-11%8%14%5%5%Return on equityROE
−1%5%3%1%−2%5%−14%5%11%2%2%Retained to equityRetained/eq
Balance sheet
$27M$33M$18M$26M$27M$21M$29M$24M$24M$41M$41MCash & investmentsCash+inv
$148M$167M$182M$189M$177M$184M$191M$242M$238M$248M$248MReceivablesReceiv.
$136M$141M$155M$165M$195M$232M$332M$318M$347M$356M$356MInventoryInvent.
$42M$42M$53M$56M$53M$58M$73M$88M$102M$94M$94MAccounts payablePayables
$242M$266M$283M$298M$319M$357M$450M$472M$482M$510M$510MOperating working capitalOper. WC
$331M$357M$374M$397M$417M$460M$581M$616M$640M$673M$673MCurrent assetsCur. assets
$114M$150M$161M$188M$190M$197M$297M$311M$278M$315M$315MCurrent liabilitiesCur. liab.
2.9×2.4×2.3×2.1×2.2×2.3×2.0×2.0×2.3×2.1×2.1×Current ratioCurr. ratio
$398M$402M$400M$618M$618M$618M$815M$807M$805M$807M$807MGoodwillGoodwill
$1.3B$1.4B$1.4B$1.8B$1.8B$1.8B$2.3B$2.3B$2.3B$2.3B$2.3BTotal assetsAssets
$498M$486M$457M$769M$754M$685M$1.1B$974M$906M$835M$835MTotal debtDebt
$471M$454M$439M$743M$726M$664M$1.0B$950M$881M$794M$794MNet debt / (cash)Net debt
2.5×2.6×3.5×1.9×1.0×3.1×2.4×3.0×5.4×3.3×3.3×Interest coverageInt. cov.
$581M$631M$662M$710M$709M$785M$746M$834M$963M$1.0B$1.0BShareholders’ equityEquity
1.1%1.1%1.2%1.2%1.5%1.6%2.1%1.9%2.0%2.1%2.1%Stock comp / revenueSBC/rev
Per share
28.0M28.2M28.9M29.5M29.5M32.2M30.0M31.5M31.1M31.1M31.1MShares out (diluted)Shares
$27.30$28.27$29.76$32.38$29.27$31.37$34.80$39.46$41.96$44.13$44.13Revenue / shareRev/sh
$0.52$1.97$1.41$0.97$0.32$1.94$-2.68$2.04$4.25$1.51$1.51EPS (diluted)EPS
$0.90$1.87$2.01$2.55$1.75$3.01$0.58$3.37$4.94$4.84$4.84Owner earnings / shareOE/sh
$0.90$1.87$2.01$2.55$1.75$3.01$0.39$3.37$4.94$4.84$4.84Free cash flow / shareFCF/sh
$0.79$0.79$0.78$0.77$0.77$0.72$0.80$0.78$0.79$0.79$0.79Dividends / shareDiv/sh
$0.53$0.46$0.57$0.68$0.44$0.46$0.73$0.60$0.42$0.64$0.64Cap. spending / shareCapex/sh
$20.76$22.41$22.92$24.09$24.06$24.38$24.82$26.44$30.90$33.17$33.17Book value / shareBVPS
Per-share growththe realized rate an owner's share compounded
9-yr5-yr
Revenue / share+5.5%/yr+8.6%/yr
Owner earnings / share+20.6%/yr+22.6%/yr
EPS+12.5%/yr+36.1%/yr
Dividends / share+0.0%/yr+0.5%/yr
Capital spending / share+2.1%/yr+7.6%/yr
Book value / share+5.3%/yr+6.6%/yr

The year, in the company's words

the filing →

Verbatim from the 10-K's management discussion. Each sentence is shown only because its subject, direction, and stated figures check out against the filed numbers on this page. The words are the company's; the arithmetic is the record's.

  • Revenue+5.2%
    “Net sales increased 5.2% in 2025 due to growth in both the orthopedic surgery and general surgery product lines. •Orthopedic surgery sales increased 5.6% in 2025 as a result of growth in our sports medicine and BioBrace® product offerings. •General surgery sales increased 4.9% in 2025 as a result of growth in our AirSeal®, specimen bags and biliary product offerings.”
    ✓ figure matches the filed record

The record, charted

FY2016–2025

Each measure over its full record; the current point and the worst year marked.

Share count
31Mpeak FY2021
ROIC
4%low FY2016
Gross margin
55%low FY2020
Net debt ÷ owner earnings
5.3×peak FY2022

Owner earnings vs. net income

Owner earningsNet income

The accountant's number, and the cash an owner can take; the gap is the tell.

$151Mowner earningsvs.$47Mnet incomelow FY2022

Where the cash went

ReinvestBuybacksDividendsAcquisitionsRetainedBeyond op. cash

Each year's outlays against its operating cash: the mix, and how it drifts. The hatched cap is spending beyond that year's operating cash — financed from the balance sheet or borrowing, not operations.

FY2016FY2025

Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.

In fiscal 2025 the business turned $47M of profit into $151M of owner earnings: more cash than the profit line showed, after the non-cash charges and the capital it put back in.

Reported net income$47M
Owner earnings$151M · 11% of revenue
FY2025FY2024FY2023FY2022FY2021
Reported net income$47M$132M$64M($81M)$63M
Depreciation & amortizationnon-cash charge added back+$17M+$17M+$16M+$16M+$16M
Stock-based compensationreal costnon-cash, but a real cost+$28M+$26M+$24M+$22M+$16M
Working capital & othertiming of cash in and out, other non-cash items+$78M−$8M+$20M+$76M+$16M
Cash from operations$171M$167M$125M$33M$112M
Maintenance capital expenditurethe spending needed just to hold position and volume−$20M−$13M−$19M−$16M−$15M
Owner earnings$151M$154M$106M$17M$97M
Growth capital expenditurediscretionary; spent to get bigger, not to stand still−$6M
Free cash flow$151M$154M$106M$12M$97M
Owner-earnings marginowner earnings ÷ revenue11%12%9%2%10%

Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position . The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $28M), owner earnings is nearer $123M.

Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.

III

Quality & stewardship

Returns, the balance sheet, capital allocation, and pay.

Owner’s Scorecard

FY2025 10-K · source on SEC EDGAR →

Will it survive?

  • Adequate
    Operating income $103M ÷ interest expense $31M
    What this means

    Comfortable in a normal year, but below the margin of safety Graham looked for. Worth checking how stable the coverage has been across a full cycle.

  • How heavy is the debt, net of cash? $794M · 7.7× operating profit
    Heavy net debt
    Cash $41M − debt $835M
    What this means

    Netting $41M of cash and short-term investments against $835M of debt leaves $794M owed, about 7.7× a year's operating profit (8.1× on the gross debt, before the cash). Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.

  • Long (60+ days)
    DSO 66 + DIO 208 − DPO 55 days
    What this means

    Days cash is tied up between paying suppliers and collecting from customers. Lower is better; a long cycle means growth itself eats cash.

Is it a good business?

  • Below average through the cycle
    9-yr median, range 3%–9%; 4% latest = NOPAT $68M ÷ invested capital $1.8B
    Industry peers: median 4%
    What this means

    The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. The headline is the median of the last 9 years (it ran 4% most recently), so one peak or trough year doesn't set the verdict. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.

  • Solid through the cycle
    10-yr median margin, range 2%–12%; latest $151M = operating cash $171M − maintenance capex $20M
    Industry peers: median 8%
    What this means

    What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's 11% of revenue this year, a 7% median across 10 years. Treating stock comp as the real expense it is (less $28M of SBC) leaves $123M.

  • Cash-backed
    Cash from ops $171M ÷ net income $47M
    What this means

    How much of reported profit showed up as operating cash. Above 1× is reassuring; well below suggests earnings lean on accruals. One year is noisy, growth and working-capital swings distort it, and this is operating cash, not free cash. Watch the multi-year trend.

How is the cash used?

  • Reinvests most of it
    Dividends + buybacks $25M ÷ Owner Earnings $151M
    What this means

    Of $151M Owner Earnings, $25M (16%) went back to shareholders, $25M dividends, $0 buybacks. Returning most of it is the mark of a mature business with little left to reinvest at a high return; reinvesting most could mean a long runway, or empire-building. The split doesn't say which; the return earned on it (see ROIC) does.

  • Investing or harvesting? 1.16×
    Maintaining
    Capex $20M ÷ depreciation $17M
    What this means

    Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.

Graham’s defensive tests · 3 of 6 met

Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.

  • Adequate size Near
    Revenue ≥ $2B · $1.4B
    What this means

    Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.

  • Strong liquidity Pass
    Current ratio ≥ 2× · 2.14×
    What this means

    Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.

  • Conservative debt Miss
    Debt ≤ working capital · $835M vs $358M WC
    What this means

    Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.

  • Earnings stability Near
    A profit every year (10-yr record) · 1 loss year
    What this means

    Graham wanted earnings in each of the past ten years, the stability a defensive owner leans on.

  • Dividend record Pass
    Uninterrupted dividends · paid every year (10)
    What this means

    An unbroken dividend was Graham's mark of durability. He wanted twenty years; the filings show about ten, and a single suspension breaks the streak. Non-payers, many fine modern compounders, fall outside his defensive net by design.

  • Earnings growth Pass
    Earnings +33% over the record · +120%
    What this means

    At least a third more earnings than a decade ago, averaging three years at each end. Net income (not per-share), so stock splits don't distort it, buybacks and dilution show up in the share-count line instead.

  • Moderate price
    P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
    What this means

    Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $2.64/share (latest year $1.53), the averaged base the calculator's gate runs on, and book value is $33.51/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.

Durability & moat, 2016–2025

Whether the record’s returns held, and what the capital reinvested earned.

  • Profitable years 9 of 10
    What this means

    Lost money in 1 year(s), look at what happened there before trusting the average.

  • Return on capital ≥ 15% 0 of 10 yrs
    What this means

    A moat shows up as a high return on invested capital that holds year after year, not one good vintage.

  • Operating margin 6% → 11% (3-yr avg ends)
    What this means

    Through the cycle the operating margin widened — about 6% early to 11% lately, median 7% — pricing power intact or improving.

  • Reinvestment, incremental ROIC 9%
    What this means

    Reinvested capital came back at only a modest incremental return — near the cost of capital, where extra growth adds little per dollar. The record shows whether it is a soft stretch or a thinning moat.

  • Owner earnings growth +16%/yr
    What this means

    Owner earnings grew about 16% a year over the record.

  • Worst year 2016 · 4.9% op. margin
    What this means

    Stayed profitable even in its hardest year, the resilience that survives recessions.

  • Share count +1.2%/yr
    What this means

    The share count is rising, dilution works against you on a per-share basis.

  • Dividend record rising
    What this means

    Paid and raised the dividend across the record, the continuity Graham prized.

Does AI threaten the moat?

Low contestability

The moat is physical, regulated or balance-sheet-funded, the kind AI cuts costs within but does not contest.

In its own filing A competitive risk, new this year

Its FY2025 10-K names artificial intelligence as a competitive threat, in language that was not in the prior year's filing.

“We will also update and implement new software of information technology from time to time and any material disruptions, delays or deficiencies in the design and implementation of such updated or new technology may have an adverse affect on our operations and operating results. 18 Our use of artificial intelligence ("A…”

AI is unlikely to contest a moat that is physical, regulated or balance-sheet-funded; here it reads more as a cost tool than a threat.

Read from the filing's own risk factors, paired with the industry's structure under its SIC code; the durability is read above, the price below.

All figures as filed; the source filing is linked above.

Current Position

as of fiscal year-end, Dec 31, 2025

Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.

Current assets$673M
  • Cash & short-term investments$41M
  • Receivables$248M
  • Inventory$356M
  • Other current assets$29M
Current liabilities$315M
  • Debt due within a year$13M
  • Accounts payable$94M
  • Other current liabilities$208M
Current ratio2.14×all current assets ÷ what's due · Graham looked for 2×
Quick ratio1.01×stricter: inventory excluded
Cash ratio0.13×strictest: cash alone against what's due
Working capital$358Mthe cushion left after near-term bills
Debt due this year vs. cash$13M due · $41M cash covered by cash on hand, no refinancing forced · both figures from the Dec 31, 2025 balance sheet
Revenue, latest quarter vs. a year ago+6.7%the freshest read on whether the business is still growing
Current ratio, recent quarters2.2× → 2.1×
Deeper floors
Tangible book value($356M)equity stripped of goodwill & intangibles
Net current asset value($620M)Graham's net-net: current assets less all liabilities
Debt incl. operating leases$847M$53M of it operating leases

From the company's latest filing.

How the cash was used, 2016–2025

Over the record, the business generated $948M of operating cash; how management split it reads as a balanced allocator, splitting cash between the business, owners, and the balance sheet.

  • Reinvested$166M · 17%
  • Dividends$233M · 25%
  • Retained (debt / cash)$549M · 58%
  • Returned to owners$233M

    30% of the owner earnings the business produced over the span, $233M as dividends and $0 as buybacks.

  • Source of fundingOperating cash

    Operating cash covered reinvestment and returns; over the span debt rose $336M and cash and short-term investments rose $13M.

  • Net change in share count11.4%

    The diluted count rose from 28M to 31M: issuance (stock pay, deals) outran any buybacks, so owners were diluted on net.

  • Dividend record$0.79/sh

    Paid in 10 of the years on record, the per-share dividend growing about 0% a year. It was never cut over the span.

  • Return on what it retained65%

    Of the earnings it kept rather than paid out ($142M over the span), annual owner earnings (first three years vs last three) grew $92M, so each retained $1 added about 0.65 of yearly owner earnings. Buffett's test, run on owner earnings instead of market value.

Buybacks are gross of stock issued to staff; the share-count line above is the net of that, the figure that decides whether owners gained. The average price paid blends a year of purchases (and any accelerated repurchase), so it is close, not exact. The record of where the cash went and on what terms.

Acquisitions & goodwill

from the balance sheet & the 10-year cash-flow record

Goodwill grows only when a company acquires and falls only when it concedes it overpaid. The size of that bet, the cash put into buying rather than building, and how much has already been written off.

Goodwill & intangibles$1.4B60% of all assets; the premium carried on the balance sheet for businesses acquired
Against book equity78%goodwill is this share of book equity; the rest is the company’s own retained and paid-in capital
Cash spent acquiring$228Mover 10 years buying other businesses, against $166M of capital spent building

None written down over the record; the goodwill is still carried at full cost. That is the deals holding their value on the books so far; whether they keep doing so is the test an owner watches, since the write-down, when it comes, is the admission the price was too high.

Goodwill, acquired intangibles and equity from the latest balance sheet; acquisition spend and write-downs summed across the 10-year record, from the company's own filings.

Management, ownership & pay

read the proxy →

From the proxy: how much of the business the people running it own, and how they are paid, beside what the business earned for its owners in the same years.

Fiscal yearChief executivePay, as filed“Actually paid”Owner earnings
2021Curt R. Hartman$9.4M$23.2M$97M
2022Curt R. Hartman$7.8M−$8.3M$17M
2023Curt R. Hartman$7.8M$13.3M$106M
2024Curt R. Hartman$7.4M−$4.8M$154M
2025Patrick J. Beyer$7.6M$2.5M$151M

Both pay figures are the company’s own, from the pay-versus-performance table its proxy statement files. “As filed” is the Summary Compensation Table total: salary, bonus, and equity awards at their value on the day of grant. “Actually paid” is the SEC’s prescribed recalculation, which re-marks those equity awards to what they became as they vested; it can swing far above or below the filed figure in either direction, and negative years occur. Owner earnings are the whole business's, from the record above, for the same fiscal years.

  • Insider ownership<1%

    The stake all directors and executive officers hold together, per the 2026 proxy: skin in the game, the first thing Munger reads.

  • CEO pay ratio152:1

    What the chief earns for every dollar the median employee makes, per the 2026 proxy. A high ratio alone settles nothing; some businesses are genuinely top-heavy in scarce skill. A runaway figure is where Buffett starts asking whether the board is doing its job.

  • Stock-based compensation$28M

    The slice of the business handed to employees in shares this year, 2% of revenue, equal to 28% of operating profit. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.

Inverting the record

Invert: instead of why CONMED is a good business, the question is what would make owning it a mistake, and whether those marks are in the record. Disconfirming tests across 2016–2025.

1 of the 5 tests turned up something to look into; the other 4 came back clean.

  • Look hereDid the share count rise anyway?11.4%

    Diluted shares grew 11.4% over 2016–2025. Owners were diluted on net; each share owns less of the business than it did. Read the buyback line beside this one, not on its own.

And these came back clean
  • Is it less profitable than it was?
  • Did debt outgrow the business?
  • Did reported profit become cash?
  • Did receivables and inventory outpace sales?

Each test is read from the filings and is noisy alone; a flag can mark a cyclical trough or a year of heavy investment as easily as a problem. The filing says which.

Peers, Medical Devices & Equipment

The same industry, side by side on owner economics. Each figure is a through-cycle median, so a peak or trough year can’t distort it; the group median at the foot is the line to read each against.

CompanyRevenueGross marginOp. marginROICOwner earn. margin
TFXTeleflex$2.0B55%16.6%7%13%
IARTIntegra Lifesciences Holdings Corp$1.6B62%7.4%4%8%
MASIMasimo$1.5B66%21.3%30%14%
PENPenumbra$1.4B65%0.5%0%3%
LIVNLivaNova PLC$1.4B67%-3.0%-4%6%
CNMDCONMED$1.4B55%7.9%5%7%
HAEHaemonetics$1.3B50%10.4%7%11%
TNDMTandem Diabetes Care$1.0B52%-15.0%-24%-1%
Group median58%7.6%5%7%
IV

The price

What a price has to assume.

What the price implies

reverse-DCF

Type today's close and see the owner-earnings growth you'd have to believe to justify it, beside what CONMED has delivered.

CONMED’s latest year runs above its own through-cycle margin — the reported figure may flatter a peak. So the tool opens on the through-cycle base, Graham’s averaging cutting both ways; clear the toggle below to read the latest year exactly as reported.

$

Through the cycle, CONMED earns about $101M on its 7.3% median owner-earnings margin. This year’s 11.0% margin runs above that; the reported figure may flatter a peak you'd be paying on. Normalize, below, values the price on that through-cycle figure rather than the latest year. It comes pre-checked here for that reason, the same rule that already normalizes a trough; clear it to price the year as filed.

Base

The assumptions

9.0% = the 4.55% 10-year Treasury (Jul 15, 2026) + 4.45 points of equity premium. The rate you require is yours to set.

Enter a price above to run it.

Implied by the price
Owner-earnings growth · ’21→’25+28%/yr
Owner-earnings growth · ’16→’25+16%/yr
Owner-earnings yield
P/E (3-yr earnings ’23–’25)
P/B
Graham’s price gate

Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.

Against a high-grade bond: Graham’s yardstick bond yield%

Prefilled with the 10-year Treasury (4.55%, as of Jul 15, 2026). Edit it for today’s exact figure, or a AAA corporate yield.

Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.

Owner earnings $151M on 31M shares outstanding, per the 10-K cover, as of 2026-02-11; net debt $794M. The base opens on the through-cycle figure (the latest year sits above the record’s own median, and Graham’s averaging cuts both ways); clear Normalize to use the year as filed. Net of stock comp treats option pay as the expense it is. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.

Cite: Owner Scorecard, "CONMED (CNMD), the owner's record," https://ownerscorecard.com/c/CNMD, data as of 2026-07-09.

Manual order: ← CNM its page in the Manual CNNE →

Industry order: ← CLPT the Medical Devices & Equipment chapter COO →